These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5469312)

  • 61. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Formulary submission process catches on ... slowly.
    Cross M
    Manag Care; 2002 Nov; 11(11):32-6. PubMed ID: 12491856
    [No Abstract]   [Full Text] [Related]  

  • 63. Implementation of a once-daily aminoglycoside program in a large community-teaching hospital.
    Nicolau DP; Belliveau PP; Nightingale CH; Quintiliani R; Freeman CD
    Hosp Pharm; 1995 Aug; 30(8):674-6, 679-80. PubMed ID: 10144645
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Adverse drug reactions and the P & T committee.
    Lipman AG
    Hosp Formul; 1980 Jul; 15(7):580. PubMed ID: 10247654
    [No Abstract]   [Full Text] [Related]  

  • 65. [More stringent requirements in connection with the choice of drugs. Members of the drug committees in Stockholm deliver an annual declaration of challengeability].
    Sjöqvist F
    Lakartidningen; 2001 Feb; 98(6):541-3. PubMed ID: 11475240
    [No Abstract]   [Full Text] [Related]  

  • 66. $50 M for drug comparisons could produce valuable results.
    Carroll J
    Manag Care; 2004 Apr; 13(4):9-10. PubMed ID: 15146713
    [No Abstract]   [Full Text] [Related]  

  • 67. [On the danger of errors in drug administration].
    Kohlhaas M
    Dtsch Med Wochenschr; 1968 Jul; 93(29):1411-2. PubMed ID: 5658747
    [No Abstract]   [Full Text] [Related]  

  • 68. Effective decision-making in a changing healthcare environment: a P & T Committee interview.
    Zoloth A; Yon JL; Woolf R
    Hosp Formul; 1989 Feb; 24(2):85-7, 90, 93 passim. PubMed ID: 10291815
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [The admission of drugs in the Netherlands].
    ten Ham M
    Ned Tijdschr Geneeskd; 1983 May; 127(22):968-71. PubMed ID: 6866153
    [No Abstract]   [Full Text] [Related]  

  • 70. Raising the bar in the formulary decision process.
    Navarro RP
    Manag Care Interface; 1999 Jul; 12(7):51, 54. PubMed ID: 10539501
    [No Abstract]   [Full Text] [Related]  

  • 71. The profession of pharmacy.
    Walton CA
    Pharmacology; 1972; 8(1):208-11. PubMed ID: 4644651
    [No Abstract]   [Full Text] [Related]  

  • 72. Managed care guidelines for the economic evaluation of pharmaceuticals.
    Langley PC; Martin RE
    Am J Manag Care; 1997 Jul; 3(7):1013-21. PubMed ID: 10173366
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Management of a restricted drugs policy in hospital: the first five years' experience.
    Collier J; Foster J
    Lancet; 1985 Feb; 1(8424):331-3. PubMed ID: 2857375
    [No Abstract]   [Full Text] [Related]  

  • 74. The Academy of Managed Care Pharmacy's format for formulary submission.
    Penna P
    Manag Care Interface; 2001 Jun; 14(6):61-2. PubMed ID: 11432152
    [No Abstract]   [Full Text] [Related]  

  • 75. [Pharmacy committees and the prescription of drugs].
    Boréus LO
    Lakartidningen; 1969 Jun; 66():Suppl II:44+. PubMed ID: 5384122
    [No Abstract]   [Full Text] [Related]  

  • 76. Adverse drug reaction program using pharmacist and nurse monitors.
    Miwa LJ; Randall RJ
    Hosp Formul; 1986 Nov; 21(11):1140-3, 1146. PubMed ID: 10279322
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Concerns of a pediatric hospital's P & T Committee: quality care emphasized over cost considerations.
    Reiley T; Wedemeyer H
    Hosp Formul; 1990 Oct; 25(10):1084-7, 1091. PubMed ID: 10107390
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Enterprise liability for bad outcomes from drug therapy: the doctor, the hospital, the pharmacy, and the drug firm.
    Furrow BR
    Spec Law Dig Health Care Law; 1998 Apr; (229):9-69. PubMed ID: 10178162
    [No Abstract]   [Full Text] [Related]  

  • 79. Raising the bar. Barcoding has the potential to dramatically reduce medication errors.
    Goth G
    Healthc Inform; 2006 Apr; 23(4):38-41. PubMed ID: 16676641
    [No Abstract]   [Full Text] [Related]  

  • 80. [Clinical therapeutic trials].
    Mathé G
    Bull Cancer; 1974; 61(2):191-212. PubMed ID: 4619025
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.